Today: 29 April 2026
Browse Category

NASDAQ:NOK 17 September 2025 - 6 April 2026

Nokia Stock Near High Ahead of AGM as Board Change, Buyback Powers and AI Push Come Into Focus

Nokia Stock Near High Ahead of AGM as Board Change, Buyback Powers and AI Push Come Into Focus

Nokia’s U.S. shares closed unchanged at $8.82 ahead of Thursday’s annual meeting, where shareholders will vote on a new chair, board member, and capital return plans. The meeting comes before first-quarter results on April 23, with CEO Justin Hotard warning of weaker sales outside patent licensing. Nokia recently announced a major 5G deal with Virgin Media O2 in the UK. Analyst ratings have improved, but expectations remain cautious.
6 April 2026
···
Nokia (NOK) News Today, November 13, 2025: Nvidia’s $1B Stake Closes as AI, 5G and Sustainability Push Stock Higher

Nokia (NOK) News Today, November 13, 2025: Nvidia’s $1B Stake Closes as AI, 5G and Sustainability Push Stock Higher

Nokia completed a $1 billion share issuance to Nvidia, giving Nvidia a 2.9% stake and deepening their AI and 5G partnership. Nokia’s U.S. ADR traded near $7.03, steady after gains since the Nvidia deal was announced. New shares will begin trading in Helsinki on November 14. Year-to-date, Nokia’s total return exceeds 60%, far outpacing the Helsinki index.
13 November 2025
····
From VAR to VR: How High-Tech is Revolutionizing the 2025 Champions League

From VAR to VR: How High-Tech is Revolutionizing the 2025 Champions League

Champions League matches now use AI-driven semi-automated offside technology, cutting offside decisions from minutes to about 25 seconds with 3D replays for fans. Players’ movements are tracked in real time, feeding live stats to coaches and broadcasts. Stadiums like Munich’s Allianz Arena feature 5G and digital ticketing. Facial recognition is being tested to block banned fans at some venues.
17 September 2025
····

Stock Market Today

  • McKesson Stock Seen Undervalued Despite Recent Price Plateau
    April 29, 2026, 6:27 AM EDT. McKesson (MCK) shares hover around $835 after a substantial 343% gain over five years. The stock experienced minor short-term declines, including a 0.9% drop over seven days and is up 1.4% year-to-date. Analysts' Discounted Cash Flow (DCF) models indicate the stock could be undervalued by approximately 45%, with intrinsic value estimated near $1,521 per share. McKesson trades at a price-to-earnings (P/E) ratio of 23.6, slightly below the healthcare sector average of 24.3. The company's steady cash flow and valuation metrics suggest potential investment value despite recent price cooling.

Latest article

South Africa Stock Market Today: JSE Slips as Rand Wobbles Before Fed Decision

South Africa Stock Market Today: JSE Slips as Rand Wobbles Before Fed Decision

29 April 2026
The JSE All Share fell 0.28% and the Top 40 dropped 0.36% by late morning Wednesday as investors reduced risk ahead of the U.S. Federal Reserve decision. The rand weakened to 16.5550 per dollar, pressured by high oil prices and global uncertainty. Richemont, Gold Fields, and AngloGold Ashanti declined, while banks gained modestly. Canal+ confirmed plans to list in Johannesburg on June 3.
Ireland Stock Market Today: ISEQ Climbs as Glanbia Surge Offsets Ryanair Warning

Ireland Stock Market Today: ISEQ Climbs as Glanbia Surge Offsets Ryanair Warning

29 April 2026
Glanbia shares jumped 10.84% in Dublin on Wednesday after reporting a 7.2% rise in first-quarter like-for-like revenue, lifting the ISEQ All Share 0.59% to 12,358.83. The ISEQ 20 Capped gained 1.16%, while Ryanair fell 1.04% after CEO Michael O’Leary warned fares may stay flat due to Middle East conflict. The broader STOXX 600 slipped 0.3% as European markets lagged.
Go toTop